What is DNASTAR?
DNASTAR is a prominent provider of advanced bioinformatics software solutions tailored for life science researchers. Their comprehensive suite of tools facilitates critical tasks in sequence analysis, molecular biology, genomics, and protein analysis. The flagship Lasergene platform offers integrated capabilities for cloning, primer design, and protein structure prediction, designed for user-friendliness and accessibility. DNASTAR's commitment to innovation drives continuous enhancement of its software, supporting the entire research pipeline for academic institutions, biotechnology firms, and pharmaceutical companies, thereby boosting research efficiency and accuracy.
How much funding has DNASTAR raised?
DNASTAR has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for DNASTAR?
With its large-scale late-stage funding, DNASTAR is strategically positioned for accelerated expansion and further development of its bioinformatics platforms. The recent major strategic investment likely signals an intent to enhance market penetration, explore new technological frontiers in genomics and data analysis, or potentially pursue strategic acquisitions. This capital infusion will empower DNASTAR to solidify its leadership in the competitive life science software market, driving innovation and supporting the evolving needs of researchers worldwide.
See full DNASTAR company page
